Report overview
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
This report aims to provide a comprehensive presentation of the global market for mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Therapy. This report contains market size and forecasts of mRNA Therapy in global, including the following market information:
Global mRNA Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global mRNA Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of mRNA Therapy include Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca and CureVac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global mRNA Therapy Market Segment Percentages, by Type, 2022 (%)
Vaccine
Drugs
Global mRNA Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global mRNA Therapy Market Segment Percentages, by Application, 2022 (%)
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
Global mRNA Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global mRNA Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies mRNA Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac
Outline of Major Chapters:
Chapter 1: Introduces the definition of mRNA Therapy, market overview.
Chapter 2: Global mRNA Therapy market size in revenue.
Chapter 3: Detailed analysis of mRNA Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of mRNA Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
